Cobimetinib Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 20mg
Reference Brands: Cotellic (USA/EU)
Category: Oncology Cancer Care
Cobimetinib is a MEK inhibitor used in combination with vemurafenib to treat patients with unresectable or metastatic melanoma that has a BRAF V600E or V600K mutation. It works by blocking the MEK1 and MEK2 enzymes in the MAPK signaling pathway, which helps slow or stop cancer cell growth. Cobimetinib is available in Tablets and strengths such as 20mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Cobimetinib is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Cobimetinib can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Gemtuzumab Ozogamicin
Strength:
4.5 mg
Form: Injection
Reference Brands: Mylotarg (USA)
View Details
Tafasitamab‑Cxix
Strength:
200 mg
Form: Injection
Reference Brands: Monjuvi (USA), Minjuvi (EU)
View Details
Dordaviprone Hydrochloride
Strength:
125 mg
Form: Capsules
Reference Brands: Modeyso (USA)
View Details
Quick Response Guaranteed | Verified Suppliers
